In cancer, AMPK exhibits context- and isoform-dependent roles: it acts as a tumor suppressor by limiting anabolic growth and promoting autophagy during early tumorigenesis, but can also support tumor survival under metabolic stress once malignancy is established (40–46). Here, PRKAA2 is linked to neoplasm.